XPF antibody | knockout validation | Santa Cruz sc-136153

This is a knockout-validated antibody summary, based on the publication "Repair protein persistence at DNA lesions characterizes XPF defect with Cockayne syndrome features", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

XPF antibody | knockout validation | Santa Cruz sc-136153 figure 1
Figure 1. (A) Immunoblot showing XPF and ERCC1 expression in U2OS, XPF knockout (KO) and XPF-GFP (XPF-wt) expressing XPF KO cells. Ku70 staining is shown as loading control. (B) Immunofluorescence pictures showing localization of endogenous XPF in U2OS (top panel) and XPF-wt in XPF KO cells (bottom panel) after UVC irradiation. Scale bar: 5 um. Please see Figure XXXX in the article [1].
Antibody information

Mouse monoclonal IgG1 (kappa light chain)

Company: Santa Cruz

Antibody: XPF

Catalog number: sc-136153

Summary: Mouse monoclonal IgG1 (kappa light chain) against His-tagged recombinant protein corresponding to amino acids 629-905 of human XPF. Recommended for detection of XPF of mouse, rat and human origin by western blot, immunoprecipitation and ELISA.

Validation Method

Western blot

Sample

Parental, XPF-knockout and XPF-GFP reconstituted U2OS cell lines.

Blocking agent

WB: 2% BSA.

IC: PBS containing 0.15% glycine and 0.5% BSA.

Primary incubation

WB: for 2 h or overnight.

IC: for 2 h.

Secondary incubation

WB: Secondary antibodies were conjugated with CF IRDye 680 or 770 (Sigma).

IC: Alexa Fluor conjugated secondary antibodies (488, 555 and 633; Invitrogen) for 1 h.

Detection

WB: Odyssey CLx Infrared Imaging System (LI-COR Biosciences).

IC: LSM700 microscope equipped with a 40x Plan-apochromat 1.3 NA oil immersion lens (Carl Zeiss).

Clone note

The same clone (3F2/3) is sold as Santa Cruz Biotechnology sc-136153; Abcam ab85140.

References
  1. Sabatella M, Theil A, Ribeiro Silva C, Slyskova J, Thijssen K, Voskamp C, et al. Repair protein persistence at DNA lesions characterizes XPF defect with Cockayne syndrome features. Nucleic Acids Res. 2018;46:9563-9577 pubmed publisher